Kennedy Thomas Ronan has filed 6 insider transactions across 1 company since May 2023.
Most recent transaction: a grant/award of 445000 shares of cbdMD, Inc. ($YCBD) on November 28, 2025.
Activity breakdown: 3 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 28, 2025 | cbdMD, Inc. | $YCBD | Kennedy Thomas Ronan | CEO and CFO | A | Common Stock | 445000 | $0.00 | 513,722.0000 | 8,912,959 | 647.54% | 4.99% |
| May 6, 2025 | cbdMD, Inc. | $YCBD | Kennedy Thomas Ronan | CEO and CFO | C | Common Stock | 67869 | $0.00 | 74,501.0000 | 0 | 1023.36% | 0.00% |
| May 6, 2025 | cbdMD, Inc. | $YCBD | Kennedy Thomas Ronan | CEO and CFO | C | 8% Series A Cumulative Convertible Preferred Stock | 41765 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Sept. 26, 2024 | cbdMD, Inc. | $YCBD | Kennedy Thomas Ronan | CEO and CFO | P | 8% Series A Cumulative Convertible Preferred Stock | 1000 | $0.55 | 41,765.0000 | 0 | 2.45% | 0.00% |
| Sept. 23, 2024 | cbdMD, Inc. | $YCBD | Kennedy Thomas Ronan | CEO and CFO | P | 8% Series A Cumulative Convertible Preferred Stock | 38465 | $0.60 | 40,765.0000 | 0 | 1672.39% | 0.00% |
| May 3, 2023 | cbdMD, Inc. | $YCBD | Kennedy Thomas Ronan | Interim CEO and CFO | P | Common Stock | 5000 | $2.10 | 6,462.0000 | 0 | 43.62% | 0.00% |